High cumulative doxorubicin dose for advanced soft tissue sarcoma

BACKGROUND: The recommended cumulative doxorubicin dose in soft tissue sarcoma (STS) treatment was based on cardiotoxicity data from retrospective studies of breast cancer patients. However, the treatment and prognosis of STS and breast cancer are quite different, and reference to breast cancer data...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Cancer
Huvudupphovsmän: Tian, Zhichao, Yang, Yang, Yang, Yonghao, Zhang, Fan, Li, Po, Wang, Jiaqiang, Yang, Jinpo, Zhang, Peng, Yao, Weitao, Wang, Xin
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2020
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7684756/
https://ncbi.nlm.nih.gov/pubmed/33228579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07663-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk